Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal Stroma.

Coffman LG, Pearson AT, Frisbie LG, Freeman Z, Christie E, Bowtell DD, Buckanovich RJ.

Stem Cells. 2018 Oct 23. doi: 10.1002/stem.2932. [Epub ahead of print]

PMID:
30353617
2.

A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment.

Nazari F, Pearson AT, Nör JE, Jackson TL.

PLoS Comput Biol. 2018 Jan 19;14(1):e1005920. doi: 10.1371/journal.pcbi.1005920. eCollection 2018 Jan.

3.

Sampling from single-cell observations to predict tumor cell growth in-vitro and in-vivo.

Pearson AT, Ingram P, Bai S, O'Hayer P, Chung J, Yoon E, Jackson T, Buckanovich RJ.

Oncotarget. 2017 Nov 25;8(67):111176-111189. doi: 10.18632/oncotarget.22693. eCollection 2017 Dec 19.

4.

Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels.

Kim HS, Chen YC, Nör F, Warner KA, Andrews A, Wagner VP, Zhang Z, Zhang Z, Martins MD, Pearson AT, Yoon E, Nör JE.

Oncotarget. 2017 Nov 1;8(59):100339-100352. doi: 10.18632/oncotarget.22225. eCollection 2017 Nov 21.

5.

Capecitabine after Surgical Salvage in Recurrent Squamous Cell Carcinoma of Head and Neck.

Manohar PM, Sapir E, Bellile E, Swiecicki PL, Pearson AT, Prince ME, Shuman AG, Bradford CR, Chepeha DB, Wolf GT, Eisbruch A, Worden FP, Spector ME.

Otolaryngol Head Neck Surg. 2017 Dec;157(6):995-997. doi: 10.1177/0194599817722948. Epub 2017 Aug 15.

PMID:
28809131
6.

5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.

Kerk SA, Finkel KA, Pearson AT, Warner KA, Zhang Z, Nör F, Wagner VP, Vargas PA, Wicha MS, Hurt EM, Hollingsworth RE, Tice DA, Nör JE.

Clin Cancer Res. 2017 May 15;23(10):2516-2527. doi: 10.1158/1078-0432.CCR-16-1834. Epub 2016 Oct 25.

7.

Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.

Nör F, Warner KA, Zhang Z, Acasigua GA, Pearson AT, Kerk SA, Helman JI, Sant'Ana Filho M, Wang S, Nör JE.

Clin Cancer Res. 2017 Feb 15;23(4):1036-1048. doi: 10.1158/1078-0432.CCR-16-1235. Epub 2016 Aug 22.

8.

A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.

Swiecicki PL, Bellile E, Sacco AG, Pearson AT, Taylor JM, Jackson TL, Chepeha DB, Spector ME, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Sukari A, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey TE, Wang S, Nör JE, Worden FP.

Invest New Drugs. 2016 Aug;34(4):481-9. doi: 10.1007/s10637-016-0364-5. Epub 2016 May 26.

9.

Modeling head and neck cancer stem cell-mediated tumorigenesis.

Pearson AT, Jackson TL, Nör JE.

Cell Mol Life Sci. 2016 Sep;73(17):3279-89. doi: 10.1007/s00018-016-2226-x. Epub 2016 May 5. Review.

10.

Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma.

Warner KA, Nör F, Acasigua GA, Martins MD, Zhang Z, McLean SA, Spector ME, Chepeha DB, Helman J, Wick MJ, Moskaluk CA, Castilho RM, Pearson AT, Wang S, Nör JE.

Clin Cancer Res. 2016 Jul 15;22(14):3550-9. doi: 10.1158/1078-0432.CCR-15-1698. Epub 2016 Mar 2.

11.

Isolation and Characterization of Cancer Stem Cells from Primary Head and Neck Squamous Cell Carcinoma Tumors.

Kim HS, Pearson AT, Nör JE.

Methods Mol Biol. 2016;1395:241-9. doi: 10.1007/978-1-4939-3347-1_14.

12.

Patient-derived xenograft (PDX) tumors increase growth rate with time.

Pearson AT, Finkel KA, Warner KA, Nör F, Tice D, Martins MD, Jackson TL, Nör JE.

Oncotarget. 2016 Feb 16;7(7):7993-8005. doi: 10.18632/oncotarget.6919.

13.

Hyperlink-Embedded Journal Articles Improve Statistical Knowledge and Reader Satisfaction.

Saxon D, Pearson AT, Wu P.

J Grad Med Educ. 2015 Dec;7(4):654-7. doi: 10.4300/JGME-D-14-00747.1.

14.

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.

Adams A, Warner K, Pearson AT, Zhang Z, Kim HS, Mochizuki D, Basura G, Helman J, Mantesso A, Castilho RM, Wicha MS, Nör JE.

Oncotarget. 2015 Sep 29;6(29):26633-50. doi: 10.18632/oncotarget.5782.

15.

Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.

Mochizuki D, Adams A, Warner KA, Zhang Z, Pearson AT, Misawa K, McLean SA, Wolf GT, Nör JE.

Oncotarget. 2015 Sep 8;6(26):22822-35.

16.

BH3-mimetic small molecule inhibits the growth and recurrence of adenoid cystic carcinoma.

Acasigua GA, Warner KA, Nör F, Helman J, Pearson AT, Fossati AC, Wang S, Nör JE.

Oral Oncol. 2015 Sep;51(9):839-47. doi: 10.1016/j.oraloncology.2015.06.004. Epub 2015 Jun 26.

17.

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Logigian EL, Martens WB, Moxley RT 4th, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT 3rd.

Neurology. 2010 May 4;74(18):1441-8. doi: 10.1212/WNL.0b013e3181dc1a3a.

18.

Postnatal exposure to methyl mercury from fish consumption: a review and new data from the Seychelles Child Development Study.

Myers GJ, Thurston SW, Pearson AT, Davidson PW, Cox C, Shamlaye CF, Cernichiari E, Clarkson TW.

Neurotoxicology. 2009 May;30(3):338-49. doi: 10.1016/j.neuro.2009.01.005. Epub 2009 Jan 21. Review.

19.

Neonatal diethylstilbestrol alters blood pressure and CNS drinking response in SHR and WKY rats.

Lamartiniere CA, Pearson AT, Rockhold RW.

Clin Exp Hypertens A. 1988;10(5):843-57.

PMID:
3180492
20.

Duration of survival in traffic accident fatalities.

Pearson AT.

Med J Aust. 1968 Dec 14;2(24):1120. No abstract available.

PMID:
5705937

Supplemental Content

Loading ...
Support Center